

Harvard Bioscience (NASDAQ:HBIO) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Harvard Bioscience (NASDAQ:HBIO) through any online brokerage.
Other companies in Harvard Bioscience’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Waters Corp (NYSE:WAT), Agilent Technologies Inc (NYSE:A) and IQVIA Holdings Inc (NYSE:IQV).
Harvard Bioscience has a consensus price target of $18.75.
The stock price for Harvard Bioscience (NASDAQ: HBIO) is $9.29 last updated November 12, 2026 at 5:52 PM EST.
There are no upcoming dividends for Harvard Bioscience.
Harvard Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Harvard Bioscience.
Harvard Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The...